Is Compugen Stock a Good Investment?

Compugen Investment Advice

CGEN

To provide specific investment advice or recommendations on Compugen stock, we recommend investors consider the following general factors when evaluating Compugen. This will help you to make an informed decision on whether to include Compugen in one of your diversified portfolios:

Examine Compugen's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Compugen's leadership team and their track record. Good management can help Compugen navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Life Sciences Tools & Services space and any emerging trends that could impact Compugen's business and its evolving consumer preferences.
Compare Compugen's performance and market position to its competitors. Analyze how Compugen is positioned in terms of product offerings, innovation, and market share.
Check if Compugen pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Compugen's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Compugen stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Compugen is a good investment.

Sell

Buy

Strong Sell

We provide trade advice to complement the prevailing expert consensus on Compugen. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Compugen is not overpriced, please confirm all Compugen fundamentals, including its number of shares shorted, cash and equivalents, earnings per share, as well as the relationship between the revenue and current ratio . Please also double-check Compugen number of shares shorted to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Market Performance	Very Weak	Details
Volatility	Very risky	Details
Hype Condition	Over hyped	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Low	Details
Economic Sensitivity	Almost neglects market trends	Details
Investor Sentiment	Impartial	Details
Analyst Consensus	Strong Buy	Details
Financial Strenth (F Score)	Frail	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Possible Manipulator	Details

Examine Compugen Stock

Researching Compugen's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 15.0% of the company shares are held by institutions such as insurance companies. The book value of Compugen was currently reported as 0.74. The company had not issued any dividends in recent years.

To determine if Compugen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Compugen's research are outlined below:

	Compugen generated a negative expected return over the last 90 days
	Compugen may become a speculative penny stock
	Compugen has high historical volatility and very poor performance
	The company reported the previous year's revenue of 33.46 M. Net Loss for the year was (18.75 M) with profit before overhead, payroll, taxes, and interest of 6.53 M.
	Compugen currently holds about 88.21 M in cash with (35.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02.
	Compugen has a frail financial position based on the latest SEC disclosures
	Latest headline from gurufocus.com: Compugen Stock Dips Amidst Biotech Sector Movements

Compugen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Compugen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Compugen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	26th of February 2024 Upcoming Quarterly Report	View
	20th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	26th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Compugen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Compugen's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2011-11-08	2011-09-30	-0.09	-0.1	-0.01	11
2011-05-11	2011-03-31	-0.07	-0.06	0.01	14
2010-02-09	2009-12-31	-0.08	-0.07	0.01	12
2009-10-27	2009-09-30	-0.07	-0.06	0.01	14
2023-11-07	2023-09-30	-0.09	-0.11	-0.02	22
2020-07-30	2020-06-30	-0.1	-0.08	0.02	20
2018-02-21	2017-12-31	-0.2	-0.18	0.02	10
2016-11-07	2016-09-30	-0.13	-0.15	-0.02	15

Compugen's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 126.98 M.

Market Cap

52.97 Million

Compugen's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.15)	(0.16)
Return On Capital Employed	(0.14)	(0.14)
Return On Assets	(0.15)	(0.16)
Return On Equity	(0.29)	(0.30)

The company has Profit Margin (PM) of (0.22) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.51.

Determining Compugen's profitability involves analyzing its financial statements and using various financial metrics to determine if Compugen is a good buy. For example, gross profit margin measures Compugen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Compugen's profitability and make more informed investment decisions.

Evaluate Compugen's management efficiency

Compugen has return on total asset (ROA) of (0.0304) % which means that it has lost $0.0304 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1584) %, meaning that it created substantial loss on money invested by shareholders. Compugen's management efficiency ratios could be used to measure how well Compugen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 27th of November 2024, Return On Tangible Assets is likely to drop to -0.16. In addition to that, Return On Capital Employed is likely to drop to -0.14. At this time, Compugen's Non Current Assets Total are very stable compared to the past year. As of the 27th of November 2024, Total Current Assets is likely to grow to about 120.3 M, while Total Assets are likely to drop about 70.8 M.

	Last Reported	Projected for Next Year
Book Value Per Share	0.75	0.71
Tangible Book Value Per Share	0.75	0.71
Enterprise Value Over EBITDA	(13.00)	(13.65)
Price Book Value Ratio	2.67	3.68
Enterprise Value Multiple	(13.00)	(13.65)
Price Fair Value	2.67	3.68
Enterprise Value	47.5 M	45.2 M

Compugen benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.

Beta

2.647

Basic technical analysis of Compugen Stock

As of the 27th of November, Compugen shows the Standard Deviation of 3.47, risk adjusted performance of (0.10), and Mean Deviation of 2.58. Compugen technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Compugen's Outstanding Corporate Bonds

Compugen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Compugen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Compugen bonds can be classified according to their maturity, which is the date when Compugen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	MGM Resorts International Corp Bond US552953CD18	View
	AerCap Global Aviation Corp Bond US00773HAA59	View

View All Compugen Corporate Bonds

Understand Compugen's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Compugen's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	(0.10)
	Market Risk Adjusted Performance	2.3
	Mean Deviation	2.58
	Coefficient Of Variation	(696.25)
	Standard Deviation	3.47
	Variance	12.04
	Information Ratio	(0.18)
	Jensen Alpha	(0.48)
	Total Risk Alpha	(1.05)
	Treynor Ratio	2.29
	Maximum Drawdown	16.24
	Value At Risk	(7.61)
	Potential Upside	5.23
	Skewness	(0.02)
	Kurtosis	0.4887

	Risk Adjusted Performance	(0.10)
	Market Risk Adjusted Performance	2.3
	Mean Deviation	2.58
	Coefficient Of Variation	(696.25)
	Standard Deviation	3.47
	Variance	12.04
	Information Ratio	(0.18)
	Jensen Alpha	(0.48)
	Total Risk Alpha	(1.05)
	Treynor Ratio	2.29
	Maximum Drawdown	16.24
	Value At Risk	(7.61)
	Potential Upside	5.23
	Skewness	(0.02)
	Kurtosis	0.4887

Consider Compugen's intraday indicators

Compugen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Compugen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	44890.38
	Daily Balance Of Power	0.6471
	Rate Of Daily Change	1.08
	Day Median Price	1.46
	Day Typical Price	1.48
	Price Action Indicator	0.12
	Period Momentum Indicator	0.11

Compugen time-series forecasting models is one of many Compugen's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Compugen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Compugen Stock media impact

Far too much social signal, news, headlines, and media speculation about Compugen that are available to investors today. That information is available publicly through Compugen media outlets and privately through word of mouth or via Compugen internal channels. However, regardless of the origin, that massive amount of Compugen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Compugen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compugen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compugen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compugen alpha.

Compugen Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Compugen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Compugen Corporate Management

Zurit Levine	VP of Research and Discovery	Profile
Alberto Sessa	Chief Officer	Profile
Rivka Schwartz	Vice Discovery	Profile
Henry MD	Senior Officer	Profile
Eran Ophir	Chief Officer	Profile
Michelle MD	Chief Officer	Profile

When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock: